Drugs / DWP16001 Drug A
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05465668 | Jul → Aug 2022 | — | Daewoong Pharmaceutical Co. LTD. | Completed | No outcome recorded |
| Phase 1 | NCT05414591 | May → Aug 2021 | — | Daewoong Pharmaceutical Co. LTD. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DWP16001 drug A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05414591 ↗ |
| Route | Oral | “1 tablet, Oral, once daily single dose” NCT05414591 ↗ |